Quarterly report pursuant to Section 13 or 15(d)

Commitment and Contingencies (Details)

v3.7.0.1
Commitment and Contingencies (Details) - USD ($)
Jan. 17, 2017
Dec. 16, 2011
Employment Agreement Details    
Annual base salary   $ 240,000
Percent of Company's revenue that Mr. Dahl entitled to receive as monthy bonus compensation   2.00%
Exercise price per share warrants entitled   $ 0.25
Warrant for shares upon identification of bio-active agents   500,000
Warrant for shares to be issued upon upon entering into a business contract   500,000
Receives in cash payments   $ 500,000
Warrant for shares upon the Company entering into a co-development agreement   1,000,000
Partner provides atleast in cash or in-kind outlays   $ 2,000,000
Warrant for shares upon the Company entering into a co-development agreement   1,000,000
Warrant for shares upon upon the Company entering into a pharmaceutical development agreement   1,000,000
Issue shares of its common stock 1,875,000  
Professional Fees and Consulting Expenses $ 131,250  
Company could potentially be required to obligated to pay an M&A transaction fee 8.00%